E
Sutro Biopharma, Inc. STRO
$0.8578 $0.01021.20% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -208.70M -245.22M -227.46M -123.95M -124.45M
Total Depreciation and Amortization 7.47M 7.36M 7.22M 7.08M 7.02M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 34.95M 26.81M 19.80M 8.09M 28.80M
Change in Net Operating Assets -82.58M 16.37M 8.90M 3.05M 13.92M
Cash from Operations -248.86M -194.68M -191.54M -105.73M -74.72M
Capital Expenditure -3.16M -3.83M -3.10M -3.47M -2.97M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 224.26M 141.97M 221.61M 110.98M -150.83M
Cash from Investing 221.10M 138.15M 218.51M 107.51M -153.80M
Total Debt Issued -- -- -- -- --
Total Debt Repaid 0.00 0.00 -4.08M -7.21M -10.33M
Issuance of Common Stock 1.34M 97.86M 98.65M 98.65M 98.51M
Repurchase of Common Stock -338.00K -315.00K -509.00K -485.00K -444.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 0.00 -3.54M
Cash from Financing 999.00K 97.55M 94.05M 90.95M 84.20M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -26.76M 41.01M 121.02M 92.73M -144.32M